This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Betsy Rezner
Director, Process & Assay Development at Fate Therapeutics Inc.


Betsy Rezner is the Senior Director of Process & Assay Development at Fate Therapeutics located in San Diego, CA. In this role, she oversees process development and analytical method development for Fate’s novel, off-the-shelf engineered iPSC-derived NK cell cancer immunotherapy. Over the past 3 years, Betsy and her team have focused on developing robust, scalable manufacturing processes and analytical tools, thus enabling successful IND applications and initiation of several clinical studies. Previously, she led phenotypic screening initiatives to identify small molecules that modulate cellular proliferation, differentiation, and function and developed potency assays for hematopoietic cell therapy products.